Abivax (ABVX) Other financing activities (2024 - 2026)

Abivax (ABVX) posted quarterly Other financing activities of $9366.0 for Q1 2026, down 96.44% year-over-year from $262971.1 in Q1 2025, and down 83.45% quarter-over-quarter from $56598.0 in Q2 2025.

Abivax (ABVX) Other financing activities (2024 - 2026) Analysis & Trends

Abivax's Other financing activities history runs 3 years deep, the most recent figure standing at $9366.0 for Q1 2026.

  • In Q1 2026, Other financing activities fell 96.44% year-over-year to $9366.0; the TTM figure through Mar 2026 stood at $65963.9 (down 87.4% YoY), while the FY2025 annual figure was $349213.1, up 33.39% from the prior year.
  • Other financing activities for Q1 2026 stood at $9366.0, down from $56598.0 in the prior quarter.
  • The five-year high for Other financing activities was $262971.1 in Q1 2025, with the low at $1098.2 in Q3 2024.
  • The 3-year median for Other financing activities is $32982.0 (2025), against an average of $98803.7.
  • The sharpest annual moves came in 2025 and 2026: Other financing activities surged 7968.86% in 2025, then slumped 96.44% in 2026.
  • Abivax's Other financing activities stood at $1098.2 in 2024, then soared by 5053.61% to $56598.0 in 2025, then sank by 83.45% to $9366.0 in 2026.
  • Business Quant data shows ABVX's Other financing activities at $9366.0 in Q1 2026, $56598.0 in Q2 2025, and $262971.1 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Abivax 9.39 Bn 9.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 9,365.97
Mar 31, 2026 9,365.97
Jun 30, 2025 56,597.98
Jun 30, 2025 56,597.98
Mar 31, 2025 262,971.11
Mar 31, 2025 262,971.11
Sep 30, 2024 1,098.22
Sep 30, 2024 1,098.22
Jun 30, 2024 259,529.91
Jun 30, 2024 259,529.91
Mar 31, 2024 3,259.09
Mar 31, 2024 3,259.09